Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-058922
Filing Date
2008-03-17
Accepted
2008-03-17 16:43:57
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 798971
2 PATENT LICENSE AGREEMENT dex10105.htm EX-10.105 94231
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1033
4 CONSENT OF HASKELL & WHITE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2145
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 302 dex311.htm EX-31.1 8998
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 302 dex312.htm EX-31.2 8993
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 4661
8 GRAPHIC g11068graphtx.jpg GRAPHIC 57559
  Complete submission text file 0001193125-08-058922.txt   999875
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 08693437
SIC: 2834 Pharmaceutical Preparations